The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
OLMESART AMLODIPINE GPPL, OLMESART AMLODIPINE, OLMEKAR, OLMESATAN AMLODIPINE GPPL, OLMESATAN AMLO, OLMESART AMLODIPINE (Generic Partners Pty Ltd)
Product name
OLMESART AMLODIPINE GPPL, OLMESART AMLODIPINE, OLMEKAR, OLMESATAN AMLODIPINE GPPL, OLMESATAN AMLO, OLMESART AMLODIPINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
188 working days (255)
Active ingredients
Amlodipine besilate; Olmesartan medoxomil
Registration type
New generic medicine
Indication
OLMESART AMLODIPINE GPPL, OLMESART AMLODIPINE, OLMEKAR, OLMESATAN AMLODIPINE GPPL, OLMESATAN AMLO, OLMESART AMLODIPINE (tablets) is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.